Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity

Cell

Volumn 113, Issue 2, 2003, Pages 159-170

  Wang, Yong Xu ^a   Lee, Chih Hao ^a,b   Tiep, Sambath ^a   Yu, Ruth T ^a   Ham, Jungyeob ^c   Kang, Heonjoong ^c   Evans, Ronald M ^a,b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CELL ACTIVATION; CONTROLLED STUDY; ENERGY EXPENDITURE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GENETIC PREDISPOSITION; HYPERLIPIDEMIA; INGUINAL REGION; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; MUSCLE CELL; NONHUMAN; OBESITY; PREDICTION; PRIORITY JOURNAL; PROVOCATION TEST; SHORT COURSE THERAPY; SKELETAL MUSCLE; SOUTHERN BLOTTING; TRANSGENIC MOUSE; WESTERN BLOTTING; WHITE ADIPOSE TISSUE;

ANIMALIA; MUS MUSCULUS;

EID: 0037453718     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00269-1     Document Type: Article

References (35)

1. Akiyama T.E., Sakai S., Lambert G., Nicol C.J., Matsusue K., Pimprale S., Lee Y.H., Ricote M., Glass C.K., Brewer H.B. Jr., Gonzalez F.J. Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol. Cell. Biol. 22:2002;2607-2619.
2. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., Koder A., Evans R.M. PPARγ is required for placental, cardiac, and adipose tissue development. Mol. Cell. 4:1999;585-595.
3. Barak Y., Liao D., He W., Ong E.S., Nelson M.C., Olefsky J.M., Boland R., Evans R.M. Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer. Proc. Natl. Acad. Sci. USA. 99:2002;303-308.
4. Berg A.H., Combs T.P., Du X., Brownlee M., Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7:2001;947-953.
5. Berger J., Moller D.E. The mechanisms of action of PPARs. Annu. Rev. Med. 53:2002;409-435.
6. Blough E., Dineen B., Esser K. Extraction of nuclear proteins from striated muscle tissue. Biotechiques. 26:1999;202-206.
7. Chawla A., Boisvert W.A., Lee C.H., Laffitte B.A., Barak Y., Joseph S.B., Liao D., Nagy L., Edwards P.A., Curtiss L.K.et al. A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell. 7:2001;161-171. a.
8. Chawla A., Repa J.J., Evans R.M., Mangelsdorf D.J. Nuclear receptors and lipid physiology. opening the X-files Science. 294:2001;1866-1870. b.
9. Chen H., Charlat O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J., Lakey N.D., Culpepper J., Moore K.J., Breitbart R.E.et al. Evidence that the diabetes gene encodes the leptin receptor. identification of a mutation in the leptin receptor gene in db/db mice Cell. 84:1996;491-495.
10. Forman B.M., Chen J., Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ Proc. Natl. Acad. Sci. USA. 94:1997;4312-4317.
11. Hamm J.K., Park B.H., Farmer S.R. A role for C/EBPβ in regulating peroxisome proliferator-activated receptor γ activity during adipogenesis in 3T3-L1 preadipocytes. J. Biol. Chem. 276:2001;18464-18471.
12. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA. 95:1998;2509-2514.
13. Kersten S., Desvergne B., Wahli W. Roles of PPARs in health and disease. Nature. 405:2000;421-424.
14. Kopecky J., Hodny Z., Rossmeisl M., Syrovy I., Kozak L.P. Reduction of dietary obesity in aP2-Ucp transgenic mice. physiology and adipose tissue distribution Am. J. Physiol. 270:1996;E768-E775.
15. Lee G.H., Proenca R., Montez J.M., Carroll K.M., Darvishzadeh J.G., Lee J.I., Friedman J.M. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 379:1996;632-635.
16. Leibowitz M.D., Fievet C., Hennuyer N., Peinado-Onsurbe J., Duez H., Bergera J., Cullinan C.A., Sparrow C.P., Baffic J., Berger G.D.et al. Activation of PPARδ alters lipid metabolism in db/db mice. FEBS Lett. 473:2000;333-336.
17. Li A.C., Brown K.K., Silvestre M.J., Willson T.M., Palinski W., Glass C.K. Peroxisome proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 106:2000;523-531.
18. Lowell B.B., Spiegelman B.M. Towards a molecular understanding of adaptive thermogenesis. Nature. 404:2000;652-660.
19. Michalik L., Desvergne B., Tan N.S., Basu-Modak S., Escher P., Rieusset J., Peters J.M., Kaya G., Gonzalez F.J., Zakany J.et al. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)α and PPARβ mutant mice. J. Cell Biol. 154:2001;799-814.
20. Moitra J., Mason M.M., Olive M., Krylov D., Gavrilova O., Marcus-Samuels B., Feigenbaum L., Lee E., Aoyama T., Eckhaus M.et al. Life without white fat. a transgenic mouse Genes Dev. 12:1998;3168-3181.
21. Oliver W.R., Shenk J.L., Snaith M.R., Russell C.S., Plunket K.D., Bodkin N.L., Lewis M.C., Winegar D.A., Sznaidman M.L., Lambert M.H.et al. A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport. Proc. Natl. Acad. Sci. USA. 98:2001;5306-5311.
22. Peters J.M., Lee S.S.T., Li W., Ward J.M., Gavrilova O., Everett C., Reitman M.L., Hudson L.D., Gonzalez F.J. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β(δ). Mol. Cell. Biol. 20:2000;5119-5128.
23. Picard F., Géhin M., Annicotte J.-S., Rocchi S., Champy M.-F., O'Malley B.W., Chambon P., Auwerx J. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell. 111:2002;931-941.
24. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 92:1998;829-839.
25. Reddy J.K., Hashimoto T. Peroxisomal β-oxidation and peroxisome proliferator-activated receptor α an adaptive metabolic system Annu. Rev. Nutr. 21:2001;193-230.
26. Rosen E.D., Spiegelman B.M. Pparγ a nuclear regulator of metabolism, differentiation, and cell growth J. Biol. Chem. 276:2001;37731-37734.
27. Ross S.R., Graves R.A., Greenstein A., Platt K.A., Shyu H.L., Mellovitz B., Spiegelman B.M. A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc. Natl. Acad. Sci. USA. 87:1990;9590-9594.
28. Shimomura I., Hammer R.E., Richardson J.A., Ikemoto S., Bashmakov Y., Goldstein J.L., Brown M.S. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c adipose tissue. model for congenital generalized lipodystrophy Genes Dev. 12:1998;3182-3194.
29. Spiegelman B.M., Flier J.S. Obesity and the regulation of energy balance. Cell. 104:2001;531-543.
30. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., Lazar M.A. The hormone resistin links obesity to diabetes. Nature. 409:2001;307-312.
31. Tan N.S., Michalik L., Noy N., Yasmin R., Pacot C., Heim M., Fluhmann B., Desvergne B., Wahli W. Critical roles of PPARβ/δ in keratinocyte response to inflammation. Genes Dev. 15:2001;3263-3277.
32. Vosper H., Patel L., Graham T.L., Khoudoli G.A., Hill A., Macphee C.H., Pinto I., Smith S.A., Suckling K.E., Wolf C.R., Palmer C.N. The peroxisome proliferator-activated receptor δ promotes lipid accumulation in human macrophages. J. Biol. Chem. 276:2001;44258-44265.
33. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R.C., Spiegelman B.M. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 98:1999;115-124.
34. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N.et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7:2001;941-946. a.
35. Yamauchi T., Kamon J., Waki H., Murakami K., Motojima K., Komeda K., Ide T., Kubota N., Terauchi Y., Tobe K.et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance. J. Biol. Chem. 276:2001;41245-41254. b.